EU Health Research
In the spotlightWilliam C. Campbell, Satoshi Omura and Youyou Tu win Nobel prize in Physiology or Medicine
Scientific Panel for Health
European research and innovation in health is an investment in our health and, on a larger scale, in a healthy workforce, a healthy economy and lower public health bills.
EU funding and support helps health researchers to find new ways of preventing diseases, developing better diagnostics and more effective therapies, and taking up new models of care and technologies promoting health and well being. Read more...
Info Day, Horizon 2020
'Health, demographic change and wellbeing' - 18 September 2015
The Draft Work Programme 2016-2017 (SC1) is now available.
Presentations & video recordings
- Watch the Video
- 'Health, demographic change and well-being' Work Programme 2016-2017: DG RTD | DG CNECT
- Cross-cutting items: Clinical Trials, INCO, gender, SSH, communication
Clinical studies in H2020 proposals | Template
- Horizon 2020: applying for funding and rules of participation
- Two testimonials from participants under Horizon 2020 grants:
Feel-4diabetes | UNCAP - Ubiquitous INteroperable Care for Ageing People
- Fit for Health 2.0: Finding Partners & other support measures along the innovation cycle of an EU project
- Watch the Video
- Innovative Medicines Initiative - IMI
- IMI - Examples of success stories:
EU-AIMS | European Lead Factory - the pan-European platform for drug discovery
- European & Developing Countries Clinical Trials Partnership - EDCTP
- EIT-KIC-Health:The EIT at a glance | Introducing EIT Health
ICT for Health, Wellbeing and Active and healthy Ageing
Together for the Next Generation - Research and Innovation for Maternal and Newborn Health - 8 December 2015
25 August 2015
Research has a crucial role to play in improving the health of mothers and children, this being one of the priorities of the European Commission. Global coordination is essential to achieving health and wellbeing, particularly at this time of transition from MDGs to SDGs. Organised by the Directorate-General for Research and Innovation, the Research and Innovation for Maternal and Newborn Health Conference will take place on the 8 December in Brussels.
GACD funds landmark research into prevention and treatment of type 2 diabetes
20 August 2015
Members of the Global Alliance for Chronic Diseases will fund sixteen research projects to prevent and treat type 2 diabetes with over USD 30 million. The research is to take place in twenty-five low-and middle-income centres across the globe. Carlos Moedas, European Commissioner for Research, Science and Innovation, said: "Fighting a global problem requires a global effort and the European Commission is proud to contribute to the coordinated GACD initiative. Three research projects funded through Horizon 2020 and worth €10 million will help better control, manage and prevent the disease."
Dr Michael Makanga designated as next EDCTP Executive Director
14 July 2015
'During the last General Assembly of the European & Developing Countries Clinical Trials Partnership (EDCTP), Dr Michael Makanga was selected to succeed Professor Charles Mgone as Executive Director. Carlos Moedas, European Commissioner for Research, Science and Innovation, said: 'EDCTP is a flagship initiative under Horizon 2020 whose ambitious goals require commitment and leadership. Michael Makanga's invaluable experience will help EDCTP deliver and succeed on its objectives.'
First loan under InnovFin Infectious Diseases provides €10 million to improve HIV testing
13 July 2015
The European Investment Bank provided today a €10 million loan to Cavidi AB for the development of an automated version of its existing manual device for HIV viral load testing. This low cost testing device is proven to work in simplified less sophisticated laboratories thus allowing to perform, in a practical and affordable manner, regular assessment of HIV positive patients also in low-and middle-income countries.
EU response to the Ebola outbreak in West Africa
10 July 2015
The European Commission has promptly and strongly supported urgent Ebola research on potential treatments, vaccines and diagnostic tests with almost €140 million from Horizon 2020, the EU's research and innovation funding programme. Additionally, the European Commission and the European pharmaceutical industry are funding eight research projects on the development of vaccines and rapid diagnostics tests, which are key to overcoming the current Ebola crisis. These projects are run under the new 'Ebola+' programme of the Innovative Medicines Initiative (IMI) and funded with a total of €215 million, €114 million of which come from Horizon 2020. The factsheet was published on the occasion of the International Ebola Recovery Conference during which Commissioner Christos Stylianides announced €450 million to support the recovery of the three countries most affected by Ebola - Guinea, Sierra Leone and Liberia.
EU-funded study into virus mutations marks breakthrough in fight against Ebola
18 June 2015
A major contribution to eradicating Ebola has been made by the EU-funded EVIDENT project. It has confirmed that the Ebola virus has mutated at a lower rate than feared during the recent outbreak in West Africa. This means that the new diagnostic methods, treatments and vaccines under development should still be effective in the fight to eradicate the disease. Working with a budget of €1.7 million from the EU's research funding programme Horizon 2020, the EVIDENT project mapped the genetic evolution of the Ebola virus.
- News Alert
- Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa (Nature)